Generation Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Generation Bio and other ETFs, options, and stocks.About GBIO
Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process.
CEOYalonda Howze
CEOYalonda Howze
Employees115
Employees115
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2016
Founded2016
Employees115
Employees115
GBIO Key Statistics
Market cap37.93M
Market cap37.93M
Price-Earnings ratio-0.60
Price-Earnings ratio-0.60
Dividend yield—
Dividend yield—
Average volume93.34K
Average volume93.34K
High today$5.64
High today$5.64
Low today$5.40
Low today$5.40
Open price$5.56
Open price$5.56
Volume61.42K
Volume61.42K
52 Week high$12.40
52 Week high$12.40
52 Week low$3.00
52 Week low$3.00
Stock Snapshot
Generation Bio(GBIO) stock is priced at $5.64, giving the company a market capitalization of 37.93M. It carries a P/E multiple of -0.60.
On 2025-12-29, Generation Bio(GBIO) stock traded between a low of $5.40 and a high of $5.64. Shares are currently priced at $5.64, which is +4.4% above the low and 0.0% below the high.
The Generation Bio(GBIO)'s current trading volume is 61.42K, compared to an average daily volume of 93.34K.
In the last year, Generation Bio(GBIO) shares hit a 52-week high of $12.40 and a 52-week low of $3.00.
In the last year, Generation Bio(GBIO) shares hit a 52-week high of $12.40 and a 52-week low of $3.00.
People also own
Based on the portfolios of people who own GBIO. This list is generated using Robinhood data, and it’s not a recommendation.